Omega Healthcare Investors, Inc. (NYSE:OHI) Given Average Rating of "Hold" by Brokerages

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) have earned a consensus rating of "Hold" from the eleven ratings firms that are currently covering the company, Marketbeat.com reports. Six analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12 month target price among brokers that have updated their coverage on the stock in the last year is $39.70.

Several analysts recently commented on OHI shares. BMO Capital Markets raised their target price on Omega Healthcare Investors from $44.00 to $45.00 and gave the stock a "market perform" rating in a report on Monday, October 7th. Truist Financial raised their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a "hold" rating in a research note on Wednesday, September 4th. Berenberg Bank initiated coverage on shares of Omega Healthcare Investors in a research note on Friday, October 18th. They issued a "buy" rating and a $45.00 target price for the company. Scotiabank lifted their price objective on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a "sector perform" rating in a report on Monday, August 26th. Finally, Mizuho downgraded shares of Omega Healthcare Investors from an "outperform" rating to a "neutral" rating and upped their price objective for the stock from $34.00 to $35.00 in a research report on Thursday, July 25th.

Insider Transactions at Omega Healthcare Investors

In other news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In related news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now owns 100,000 shares of the company's stock, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares in the company, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.37% of the company's stock.

Institutional Trading of Omega Healthcare Investors

Several hedge funds have recently made changes to their positions in OHI. Private Advisor Group LLC lifted its holdings in Omega Healthcare Investors by 6.6% in the first quarter. Private Advisor Group LLC now owns 28,772 shares of the real estate investment trust's stock valued at $911,000 after acquiring an additional 1,783 shares during the last quarter. Vanguard Group Inc. lifted its stake in Omega Healthcare Investors by 0.5% during the first quarter. Vanguard Group Inc. now owns 35,379,787 shares of the real estate investment trust's stock worth $1,120,478,000 after purchasing an additional 165,105 shares in the last quarter. Caxton Associates LP purchased a new position in shares of Omega Healthcare Investors during the second quarter worth $1,652,000. Cetera Advisors LLC purchased a new stake in shares of Omega Healthcare Investors in the 1st quarter valued at $646,000. Finally, Handelsbanken Fonder AB lifted its stake in Omega Healthcare Investors by 24.1% during the 3rd quarter. Handelsbanken Fonder AB now owns 64,913 shares of the real estate investment trust's stock worth $2,642,000 after acquiring an additional 12,600 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Stock Performance

Shares of Omega Healthcare Investors stock traded up $0.60 during trading on Friday, hitting $41.35. 1,509,533 shares of the company's stock were exchanged, compared to its average volume of 1,555,776. The stock has a market capitalization of $11.16 billion, a price-to-earnings ratio of 30.40, a PEG ratio of 1.27 and a beta of 0.99. The business has a 50-day simple moving average of $40.59 and a 200-day simple moving average of $36.32. The company has a debt-to-equity ratio of 1.10, a quick ratio of 6.48 and a current ratio of 6.48. Omega Healthcare Investors has a 52-week low of $27.53 and a 52-week high of $44.42.

Omega Healthcare Investors Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Monday, November 4th will be issued a dividend of $0.67 per share. The ex-dividend date is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.48%. Omega Healthcare Investors's payout ratio is currently 197.06%.

Omega Healthcare Investors Company Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.